Human gamma interferon polypeptide having glutamine as the ninth n-terminal amino acid
US4835256A · kind A · utility
10Cited by
0References
1Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 3, 1987 |
| Grant date | May 30, 1989 |
| Priority date | — |
| Expiry date | Dec 3, 2007 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/142
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Disclosed is a novel DNA which shows complementarity to human interferon-.gamma. mRNA, a recombinant plasmid containing the DNA, a microorganism containing the recombinant plasmid and a method of producing the same as well as a process for producing a polypeptide having human interferon.gamma. activity using the microorganism.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.